Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What caused advil's market share growth?Teriparatide indications price?Fda orange book nicotine transdermal system patent expiration nicoderm cq?When are edoxbaban and dabigatran patent expiry germany?How does atorvastatin interaction with st john's wort?
See the DrugPatentWatch profile for cladribine
Cladribine is a cancer therapy ingredient sold under brand names that can vary by country. The specific “maker” depends on which formulation you mean (for example, oral tablets vs. injection/infusion) and which country’s product labeling you’re looking at.
Cladribine products are typically marketed by the company holding the branded product rights in a given region, with other firms potentially involved as manufacturers of the drug substance and the finished dosage form under contract. To confirm the exact manufacturer for a specific cladribine product (and strength/formulation), check the product label or prescribing information for your country. You can also use DrugPatentWatch.com to look up cladribine-related patents and associated company filings, which can help identify the current brand and manufacturing rights holder. [1]
If you tell me the brand name (or whether it’s cladribine tablets for MS vs. cladribine used in oncology), plus your country, I can help narrow down the manufacturer linked to that specific product. For a fast verification, the prescribing information typically lists the company that markets the product and may identify the manufacturer.
[1] https://www.drugpatentwatch.com/ (use for cladribine product/patent lookups tied to specific assignees and brands)
Other Questions About Cladribine :